Daniel R. Lexcen

1.3k total citations
41 papers, 570 citations indexed

About

Daniel R. Lexcen is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Surgery. According to data from OpenAlex, Daniel R. Lexcen has authored 41 papers receiving a total of 570 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Cardiology and Cardiovascular Medicine, 8 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in Daniel R. Lexcen's work include Cardiac pacing and defibrillation studies (30 papers), Cardiac electrophysiology and arrhythmias (15 papers) and Cardiac Arrhythmias and Treatments (13 papers). Daniel R. Lexcen is often cited by papers focused on Cardiac pacing and defibrillation studies (30 papers), Cardiac electrophysiology and arrhythmias (15 papers) and Cardiac Arrhythmias and Treatments (13 papers). Daniel R. Lexcen collaborates with scholars based in United States, Canada and Sweden. Daniel R. Lexcen's co-authors include Gregory J. Beilman, Kristine E. Mulier, Elizabeth R. Lusczek, Nancy E. Witowski, Khaldoun G. Tarakji, Bruce L. Wilkoff, Suneet Mittal, Charles Kennergren, Jeanne E. Poole and Alan Cheng and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and American Heart Journal.

In The Last Decade

Daniel R. Lexcen

41 papers receiving 558 citations

Peers

Countries citing papers authored by Daniel R. Lexcen

Since Specialization

Citations

This map shows the geographic impact of Daniel R. Lexcen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel R. Lexcen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel R. Lexcen more than expected).

Fields of papers citing papers by Daniel R. Lexcen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel R. Lexcen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel R. Lexcen. The network helps show where Daniel R. Lexcen may publish in the future.

Co-authorship network of co-authors of Daniel R. Lexcen

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel R. Lexcen. A scholar is included among the top collaborators of Daniel R. Lexcen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel R. Lexcen. Daniel R. Lexcen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Performance of alert transmissions from cardiac implantable electronic devices to the CareLink network: A retrospective analysis 2023 ·PubMed ·Edmond M. Cronin, (unknown), Jeff Lande, (unknown), Daniel R. Lexcen, Tyler L. Taigen	1
2	Cardioverter-defibrillator reduces mortality risk in eligible ischemic and non-ischemic cardiomyopathy patients: Sub-analysis of the multi-center Improve SCA study 2023 ·Indian Heart Journal ·Balbir Singh, Yu‐Cheng Hsieh, Yen‐Bin Liu, (unknown), Boyoung Joung, Diego Rodríguez, Alexandr Chasnoits, Dejia Huang, Shu Zhang, (unknown), Daniel R. Lexcen, Jeffrey Cerkvenik, (unknown), (unknown)	3
3	Use of healthcare claims to validate the Prevention of Arrhythmia Device Infection Trial cardiac implantable electronic device infection risk score 2021 ·EP Europace ·Fozia Ahmed, Carina Blomström‐Lundqvist, Heather L. Bloom, Christopher Cooper, Christopher R. Ellis, Andreas Goette, Arnold J. Greenspon, Charles J. Love, Jens Brock Johansen, François Philippon, Khaldoun G. Tarakji, Reece Holbrook, Lou Sherfesee, Ying Xia, Swathi Seshadri, Daniel R. Lexcen, Andrew D. Krahn	25
4	Low-temperature electrocautery reduces adverse effects from secondary cardiac implantable electronic device procedures: Insights from the WRAP-IT trial 2021 ·Heart Rhythm ·Suneet Mittal, Bruce L. Wilkoff, Jeanne E. Poole, Charles Kennergren, David J. Wright, Brett J. Berman, David Riggio, Darius P. Sholevar, (unknown), Jean B. Moubarak, Robert D. Schaller, J. Christopher Love, Robert A. Pickett, François Philippon, Zayd Eldadah, Jeffrey D. Lande, Daniel R. Lexcen, Reece Holbrook, Khaldoun G. Tarakji	4
5	Risk Factors for CIED Infection After Secondary Procedures 2021 ·JACC. Clinical electrophysiology ·Khaldoun G. Tarakji, Andrew D. Krahn, Jeanne E. Poole, Suneet Mittal, Charles Kennergren, Mauro Biffi, Panagiotis Korantzopoulos, Paolo Dallaglio, Daniel R. Lexcen, Jeff Lande, (unknown), Reece Holbrook, Bruce L. Wilkoff	23
6	Clinical performance of implantable cardioverter-defibrillator lead monitoring diagnostics 2021 ·Heart Rhythm ·Jeanne E. Poole, Charles D. Swerdlow, Khaldoun G. Tarakji, Suneet Mittal, Kenneth A. Ellenbogen, Arnold J. Greenspon, Charles Kennergren, Berit T. Philbert, (unknown), (unknown), Robert D. Schaller, Riple Hansalia, T.A. Simmers, (unknown), (unknown), Daniel R. Lexcen, Bruce D. Gunderson, Bruce L. Wilkoff	3
7	Impact of Cardiac Implantable Electronic Device Infection 2020 ·Circulation Arrhythmia and Electrophysiology ·Bruce L. Wilkoff, Giuseppe Boriani, Suneet Mittal, Jeanne E. Poole, Charles Kennergren, G. Ralph Corey, J. Christopher Love, Ralph Augostini, Svein Færestrand, (unknown), Jeff S. Healey, Reece Holbrook, Jeffrey D. Lande, Daniel R. Lexcen, Sarah Willey, Khaldoun G. Tarakji, (unknown)	54
8	Clinical Presentation, Timing, and Microbiology of CIED Infections 2020 ·JACC. Clinical electrophysiology ·M. Rizwan Sohail, G. Ralph Corey, Bruce L. Wilkoff, Jeanne E. Poole, Suneet Mittal, Charles Kennergren, Arnold J. Greenspon, Alan Cheng, Jeffrey D. Lande, Daniel R. Lexcen, Khaldoun G. Tarakji	17
9	Additional antitachycardia pacing programming strategies further reduce unnecessary implantable cardioverter-defibrillator shocks 2019 ·Heart Rhythm ·Boyoung Joung, Daniel R. Lexcen, (unknown), Marc T. Silver, Jonathan P. Piccini, Laurence D. Sterns, (unknown), Robert A. Pickett, Shufeng Liu, (unknown), Alan Cheng	5
10	Therapy From a Novel Substernal Lead 2018 ·JACC. Clinical electrophysiology ·Lucas V.A. Boersma, Béla Merkely, Petr Neužil, Ian Crozier, (unknown), Liesbeth Timmers, Zbigniew Kalarus, Lou Sherfesee, Paul DeGroot, Amy Thompson, Daniel R. Lexcen, Bradley P. Knight	28
11	ANTIBACTERIAL ENVELOPE IS ASSOCIATED WITH MEDICAL COST SAVINGS IN PATIENTS AT HIGH RISK FOR CARDIOVASCULAR IMPLANTABLE ELECTRONIC DEVICE INFECTION 2017 ·Journal of the American College of Cardiology ·(unknown), Elizabeth L. Eby, Daniel R. Lexcen, (unknown), Charles A. Henrikson, M. Rizwan Sohail, Grant R. Simons	1
12	Antibacterial Envelope Is Associated With Low Infection Rates After Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Replacement 2017 ·JACC. Clinical electrophysiology ·Charles A. Henrikson, M. Rizwan Sohail, Helbert Acosta, Eric E. Johnson, Lawrence Rosenthal, Roman Pachulski, Dan Dan, Walter Paladino, Farhat Khairallah, (unknown), Ibrahim R. Hanna, Alan Cheng, Daniel R. Lexcen, Grant R. Simons	42
13	Metabolomic analysis of survival in carbohydrate pre-fed pigs subjected to shock and polytrauma 2016 ·Molecular BioSystems ·Nancy E. Witowski, Elizabeth R. Lusczek, (unknown), Daniel R. Lexcen, Kristine E. Mulier, Andrea Wolf, (unknown), Gregory J. Beilman	2
14	Extended detection time to reduce shocks is safe in secondary prevention patients: The secondary prevention substudy of PainFree SST 2016 ·Heart Rhythm ·Laurence D. Sterns, Mathias Meine, Takashi Kurita, Albert Meijer, Angelo Auricchio, Kenji Andò, Charles T. Leng, Ken Okumura, John L. Sapp, (unknown), Daniel R. Lexcen, Bart Gerritse, Edward J. Schloss	22
15	A Four-Compartment Metabolomics Analysis of the Liver, Muscle, Serum, and Urine Response to Polytrauma with Hemorrhagic Shock following Carbohydrate Prefeed 2015 ·PLoS ONE ·Nancy E. Witowski, Elizabeth R. Lusczek, (unknown), Daniel R. Lexcen, Kristine E. Mulier, (unknown), Gregory J. Beilman	16
16	Metabolic networks in a porcine model of trauma and hemorrhagic shock demonstrate different control mechanism with carbohydrate pre-feed 2015 ·BMC Emergency Medicine ·Elizabeth R. Lusczek, Tyrone L. Vincent, Daniel R. Lexcen, Vishwesh Kulkarni, Kristine E. Mulier, Gregory J. Beilman	2
17	Feedback to providers improves evidence-based implantable cardioverter-defibrillator programming and reduces shocks 2014 ·Heart Rhythm ·Marc T. Silver, Laurence D. Sterns, Jonathan P. Piccini, Boyoung Joung, (unknown), Robert A. Pickett, (unknown), Shufeng Liu, Brett J. Peterson, Daniel R. Lexcen	11
18	Prolonged Induced Hypothermia in Hemorrhagic Shock Is Associated With Decreased Muscle Metabolism 2013 ·Shock ·Elizabeth R. Lusczek, Daniel R. Lexcen, Nancy E. Witowski, (unknown), Kristine E. Mulier, Gregory J. Beilman	12
19	Metabolomics classifies phase of care and identifies risk for mortality in a porcine model of multiple injuries and hemorrhagic shock 2012 ·The Journal of Trauma: Injury, Infection, and Critical Care ·Daniel R. Lexcen, Elizabeth R. Lusczek, Nancy E. Witowski, Kristine E. Mulier, Gregory J. Beilman	26
20	Treatment with beta-hydroxybutyrate and melatonin is associated with improved survival in a porcine model of hemorrhagic shock 2011 ·Resuscitation ·Kristine E. Mulier, Daniel R. Lexcen, (unknown), (unknown), Gregory J. Beilman	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact